The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.
Adalimumab – termination without import restrictions of investigation 337-TA-1296 of the drug adalimumab, processes for manufacturing or relating to same, and products containing same
Container openers – issuance of general exclusion order in investigation 337-TA-1255 of apparatus and methods of opening containers
In vitro products – issuance of limited exclusion order and cease and desist order in investigation 337-TA-1196 of in vitro fertilization products, components thereof, and products containing the same
Pyraclostrobin – termination without import restrictions of investigation 337-TA-1303 of products containing pyraclostrobin (a fungicide) and components thereof based on consent order
Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.